HAEMONETICS CORP/MASS (HAE) Stock Analyst Earnings Estimates
NYSE:HAE - New York Stock Exchange, Inc. - US4050241003 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 993.2M 14.10% | 1.169B 17.67% | 1.309B 12.01% | 1.408B 7.56% | 1.452B 3.13% | 1.584B 9.09% | 1.832B 15.66% | |
| EBITDA YoY % growth | 198.3M 25.59% | 261.5M 31.87% | 310.449M 18.72% | 422.29M 36.03% | 449.17M 6.37% | 473.19M 5.35% | N/A | |
| EBIT YoY % growth | 100.6M 36.68% | 168.2M 67.20% | 213.234M 26.77% | 334.1M 56.68% | 374.38M 12.06% | 428.47M 14.45% | 522.57M 21.96% | |
| Operating Margin | 10.13% | 14.39% | 16.29% | 23.73% | 25.78% | 27.05% | 28.52% | |
| EPS YoY % growth | 2.59 10.21% | 3.03 16.99% | 3.98 31.35% | 4.64 16.50% | 5.34 15.07% | 6.14 15.12% | 7.63 24.16% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.19 14.11% | 1.30 44.13% | 1.20 17.56% | 1.30 15.88% | 1.38 16.03% | 1.48 14.20% | 1.38 14.76% | 1.48 14.12% | 1.63 18.06% | 1.78 19.86% |
| Revenue Q2Q % growth | 357.49M 6.32% | 362.65M 5.64% | 352.83M 4.96% | 361.78M 4.71% | 372.35M 4.16% | 378.96M 4.50% | 374.46M 6.13% | 389.08M 7.55% | 404.86M 8.73% | 406.5M 7.27% |
| EBITDA Q2Q % growth | 105.68M -17.82% | 111.33M -20.00% | 127.81M 48.90% | 106.64M -7.85% | 118.29M 11.93% | 123.64M 11.06% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 86.655M 46.81% | 91.432M 117.99% | 84.751M 49.47% | 89.564M 56.11% | 97.518M 12.54% | 99.667M 9.01% | 98.833M 16.62% | 107.91M 20.48% | 117.27M 20.25% | 116.96M 17.35% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.12 13.13% | 1.08 | 0.04 | 3.35% |
| Q1 2025 Q2Q % growth | 1.02 -2.86% | 1.02 | 0.00 | 0.44% |
| Q4 2024 Q2Q % growth | 0.90 16.88% | 0.90 | 0.00 | -0.02% |
| Q3 2024 Q2Q % growth | 1.04 22.35% | 0.95 | 0.09 | 9.38% |
| Q2 2024 Q2Q % growth | 0.99 19.28% | 0.90 | 0.09 | 10.37% |
| Q1 2024 Q2Q % growth | 1.05 81.03% | 0.74 | 0.31 | 42.31% |
| Q4 2023 Q2Q % growth | 0.77 18.46% | 0.71 | 0.06 | 8.16% |
| Q3 2023 Q2Q % growth | 0.85 1.19% | 0.81 | 0.04 | 4.81% |
| Q2 2023 Q2Q % growth | 0.83 38.33% | 0.68 | 0.15 | 21.95% |
| Q1 2023 Q2Q % growth | 0.58 16.00% | 0.52 | 0.06 | 12.50% |
| Q4 2022 Q2Q % growth | 0.65 41.30% | 0.61 | 0.04 | 7.16% |
| Q3 2022 Q2Q % growth | 0.84 3.70% | 0.74 | 0.10 | 13.25% |
| Q2 2022 Q2Q % growth | 0.60 -3.23% | 0.61 | -0.01 | -1.99% |
| Q1 2022 Q2Q % growth | 0.50 8.70% | 0.45 | 0.05 | 10.01% |
| Q4 2021 Q2Q % growth | 0.46 -33.33% | 0.68 | -0.22 | -32.20% |
| Q3 2021 Q2Q % growth | 0.81 -13.83% | 0.66 | 0.15 | 22.57% |
| Q2 2021 Q2Q % growth | 0.62 -28.74% | 0.51 | 0.11 | 21.42% |
| Q1 2021 Q2Q % growth | 0.46 -43.21% | 0.42 | 0.04 | 10.09% |
| Q4 2020 Q2Q % growth | 0.69 13.11% | 0.74 | -0.05 | -6.36% |
| Q3 2020 Q2Q % growth | 0.94 49.21% | 0.77 | 0.17 | 22.83% |
| Q2 2020 Q2Q % growth | 0.87 55.36% | 0.70 | 0.17 | 23.99% |
| Q1 2020 Q2Q % growth | 0.81 37.29% | 0.64 | 0.17 | 26.44% |
| Q4 2019 Q2Q % growth | 0.61 | 0.56 | 0.05 | 9.47% |
| Q3 2019 Q2Q % growth | 0.63 | 0.60 | 0.03 | 5.47% |
| Q2 2019 Q2Q % growth | 0.56 | 0.55 | 0.01 | 2.41% |
| Q1 2019 Q2Q % growth | 0.59 | 0.42 | 0.17 | 40.76% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 345.511M 8.59% | 346.07M | -559K | -0.16% |
| Q1 2025 Q2Q % growth | 336.172M 7.98% | 338.73M | -2.558M | -0.76% |
| Q4 2024 Q2Q % growth | 343.29M 12.77% | 332.4M | 10.89M | 3.28% |
| Q3 2024 Q2Q % growth | 336.25M 10.14% | 323.5M | 12.75M | 3.94% |
| Q2 2024 Q2Q % growth | 318.183M 6.95% | 316.25M | 1.933M | 0.61% |
| Q1 2024 Q2Q % growth | 311.332M 19.06% | 295.62M | 15.712M | 5.31% |
| Q4 2023 Q2Q % growth | 304.416M 14.87% | 292.54M | 11.876M | 4.06% |
| Q3 2023 Q2Q % growth | 305.3M 17.51% | 303.47M | 1.83M | 0.60% |
| Q2 2023 Q2Q % growth | 297.5M 24.01% | 271.91M | 25.59M | 9.41% |
| Q1 2023 Q2Q % growth | 261.5M 14.44% | 251.49M | 10.01M | 3.98% |
| Q4 2022 Q2Q % growth | 265M 17.78% | 259.03M | 5.97M | 2.30% |
| Q3 2022 Q2Q % growth | 259.8M 8.07% | 269.41M | -9.61M | -3.57% |
| Q2 2022 Q2Q % growth | 239.9M 14.51% | 243.82M | -3.92M | -1.61% |
| Q1 2022 Q2Q % growth | 228.5M 16.82% | 221.55M | 6.95M | 3.14% |
| Q4 2021 Q2Q % growth | 225M -5.66% | 225.21M | -210K | -0.09% |
| Q3 2021 Q2Q % growth | 240.4M -7.18% | 226.53M | 13.87M | 6.12% |
| Q2 2021 Q2Q % growth | 209.5M -17.06% | 209.73M | -230K | -0.11% |
| Q1 2021 Q2Q % growth | 195.6M -17.99% | 200.26M | -4.66M | -2.33% |
| Q4 2020 Q2Q % growth | 238.5M -4.33% | 249M | -10.5M | -4.22% |
| Q3 2020 Q2Q % growth | 259M 4.69% | 257.96M | 1.04M | 0.40% |
| Q2 2020 Q2Q % growth | 252.6M 4.55% | 252.27M | 330K | 0.13% |
| Q1 2020 Q2Q % growth | 238.5M 4.01% | 240.09M | -1.59M | -0.66% |
| Q4 2019 Q2Q % growth | 249.3M | 253.14M | -3.84M | -1.52% |
| Q3 2019 Q2Q % growth | 247.4M | 252.63M | -5.23M | -2.07% |
| Q2 2019 Q2Q % growth | 241.6M | 235.78M | 5.82M | 2.47% |
| Q1 2019 Q2Q % growth | 229.3M | 222.15M | 7.15M | 3.22% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4.59% | 0% | -0.36% |
| Revenue | 0% | -1.37% | 0% | -0.21% |